Ratings by BTIG (Thomas Schrader)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Tiziana Life Sciences | TLSA | New Coverage | Buy (N/A) |
0.93 (1.00) |
7.53% | Details | |
| 7/1/2026 | Serina THerapeutics | SER | New Coverage | Buy (N/A) |
1.94 (1.76) |
-9.28% | Details | |
| 5/13/2026 | BioAge Labs Inc | BIOA | New Coverage | Buy (N/A) |
18.19 (5.53) |
-69.6% | Details | |
| 3/24/2026 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | NRx Pharmaceuticals, Inc. | NRXP | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2025 | NRx Pharmaceuticals, Inc. | NRXP | New Coverage | Buy (N/A) |
1.94 (2.40) |
23.71% | Details | |
| 3/20/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2025 | Coya Therapeutics | COYA | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2024 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2023 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2023 | Coya Therapeutics | COYA | New Coverage | Buy (N/A) |
5.76 (4.14) |
-28.13% | Details | |
| 10/5/2022 | Acumen Pharmaceuticals, Inc. | ABOS | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2022 | Acumen Pharmaceuticals, Inc. | ABOS | New Coverage | Buy (N/A) |
6.26 (2.06) |
-67.09% | Details | |
| 5/10/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2021 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2020 | Replimune Group | REPL | New Coverage | Buy (N/A) |
45.42 (11.99) |
-73.6% | Details | |
| 7/27/2020 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
7.41 (6.78) |
-8.5% | Details | |
| 2/28/2020 | IMV Inc. | IMV | Maintain | Buy (N/A) |
|
Details |
